CMS vs SOMN

Technical Analysis (Indicators)

Bullish Trend Analysis

CMS moved above its 50-day moving average on October 16, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for CMS crossed bullishly above the 50-day moving average on October 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 42%.

The Aroon Indicator entered an Uptrend today. In 105 of 260 cases where CMS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 40%.

Bearish Trend Analysis

The 10-day RSI Indicator for CMS moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 13 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 42%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 27 of 67 cases where CMS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 40%.

The Moving Average Convergence Divergence Histogram (MACD) for CMS turned negative on November 11, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 54 similar instances when the indicator turned negative. In 28 of the 54 cases the stock turned lower in the days that followed. This puts the odds of success at 52%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CMS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 46%.

CMS broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 45 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 50, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is 48 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. CMS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 66 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 71 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.272) is normal, around the industry mean (2.019). P/E Ratio (20.775) is within average values for comparable stocks, (14.939). Projected Growth (PEG Ratio) (2.257) is also within normal values, averaging (1.785). Dividend Yield (0.033) settles around the average of (0.054) among similar stocks. P/S Ratio (2.291) is also within normal values, averaging (187.392).

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for SOMN moved out of overbought territory on November 03, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 2 similar instances where the indicator moved out of overbought territory. In 1 of the 2 cases, the stock moved lower in the following days. This puts the odds of a move lower at 50%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 2 of 11 cases where SOMN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 18%.

The Moving Average Convergence Divergence Histogram (MACD) for SOMN turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 9 similar instances when the indicator turned negative. In 5 of the 9 cases the stock turned lower in the days that followed. This puts the odds of success at 56%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SOMN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 34%.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on SOMN as a result. In 5 of 17 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 29%.

SOMN moved above its 50-day moving average on October 14, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +2.37% 3-day Advance, the price is estimated to grow further. Considering data from situations where SOMN advanced for three days, in 15 of 48 cases, the price rose further within the following month. The odds of a continued upward trend are 31%.

The Aroon Indicator entered an Uptrend today. In 8 of 25 cases where SOMN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 32%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 10 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (2.019). SOMN has a moderately low P/E Ratio (0.000) as compared to the industry average of (14.939). SOMN's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.785). Dividend Yield (0.074) settles around the average of (0.054) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (187.392).

The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. SOMN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SOMN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 50, placing this stock worse than average.